Israel Englander Madrigal Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 10,000 shares of MDGL stock, worth $3.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,000

Previous 7,500 33.33%

Holding current value

$3.12 Million

Previous $2.1 Million 1.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$212.22 - $292.96 $1.9 Million - $2.62 Million	8,930 New	8,930 $1.9 Million
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $968,754 - $1.6 Million	5,653 New	5,653 $1.51 Million
Q2 2023 Aug 14, 2023	SELL	$203.88 - $312.0 $18.8 Million - $28.8 Million	-92,277 Reduced 76.71%	28,010 $6.47 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $27.8 Million - $36.9 Million	120,287 New	120,287 $29.1 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $445,613 - $584,955	7,357 Added 167.93%	11,738 $763,000
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $254,273 - $438,976	4,381 New	4,381 $314,000
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $882,055 - $1.61 Million	-15,782 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $595,864 - $783,256	-8,237 Reduced 34.29%	15,782 $1.34 Million
Q3 2021 Nov 15, 2021	SELL	$78.35 - $105.02 $1.71 Million - $2.3 Million	-21,864 Reduced 47.65%	24,019 $1.92 Million
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $3.84 Million - $5.43 Million	39,484 Added 617.03%	45,883 $4.47 Million
Q1 2021 May 17, 2021	BUY	$108.54 - $125.2 $694,547 - $801,154	6,399 New	6,399 $748,000
Q4 2020 Feb 16, 2021	SELL	$110.06 - $133.7 $488,006 - $592,825	-4,434 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$99.78 - $124.21 $3.63 Million - $4.51 Million	-36,341 Reduced 89.13%	4,434 $526,000
Q2 2020 Aug 14, 2020	SELL	$60.13 - $125.71 $599,616 - $1.25 Million	-9,972 Reduced 19.65%	40,775 $4.62 Million
Q1 2020 May 14, 2020	BUY	$66.76 - $93.49 $3.39 Million - $4.74 Million	50,747 New	50,747 $3.39 Million
Q4 2019 Feb 14, 2020	SELL	$84.28 - $118.5 $1.6 Million - $2.25 Million	-18,960 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$84.4 - $106.53 $567,927 - $716,840	6,729 Added 55.02%	18,960 $1.63 Million
Q2 2019 Aug 15, 2019	BUY	$91.13 - $142.5 $648,845 - $1.01 Million	7,120 Added 139.31%	12,231 $1.28 Million
Q1 2019 May 14, 2019	SELL	$103.48 - $143.84 $2.09 Million - $2.9 Million	-20,167 Reduced 79.78%	5,111 $640,000
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $2.01 Million - $4.58 Million	-21,227 Reduced 45.64%	25,278 $2.85 Million
Q2 2018 Aug 14, 2018	SELL	$101.55 - $313.9 $4.65 Million - $14.4 Million	-45,786 Reduced 49.61%	46,505 $13 Million
Q1 2018 May 15, 2018	BUY	$93.35 - $149.04 $8.25 Million - $13.2 Million	88,386 Added 2263.41%	92,291 $10.8 Million
Q4 2017 Feb 14, 2018	BUY	$39.35 - $97.37 $153,661 - $380,229	3,905	3,905 $358,000

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.34B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account